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Abstract
Background: CREB and CREM are closely related factors that regulate transcription in response to various stress,
metabolic and developmental signals. The CREMτ activator isoform is selectively expressed in haploid spermatids
and plays an essential role in murine spermiogenesis.
Results: We have used chromatin immunoprecipitation coupled to sequencing (ChIP-seq) to map CREM and CREB
target loci in round spermatids from adult mouse testis and spermatogonia derived GC1-spg cells respectively. We
identify more than 9000 genomic loci most of which are cell-specifically occupied. Despite the fact that round
spermatids correspond to a highly specialised differentiated state, our results show that they have a remarkably
accessible chromatin environment as CREM occupies more than 6700 target loci corresponding not only to the
promoters of genes selectively expressed in spermiogenesis, but also of genes involved in functions specific to
other cell types. The expression of only a small subset of these target genes are affected in the round spermatids
of CREM knockout animals. We also identify a set of intergenic binding loci some of which are associated with
H3K4 trimethylation and elongating RNA polymerase II suggesting the existence of novel CREB and CREM
regulated transcripts.
Conclusions: We demonstrate that CREM and CREB occupy a large number of promoters in highly cell specific
manner. This is the first study of CREM target promoters directly in a physiologically relevant tissue in vivo and
represents the most comprehensive experimental analysis of CREB/CREM regulatory potential to date.
Background
Cyclic AMP response element (CRE) binding protein
(CREB) and cyclic AMP response element modulator
(CREM) are highly related bZIP proteins that regulate
transcription in response to various stress, metabolic
and developmental signals [1,2]. CREB and CREM bind
to the consensus palindromic CRE 5’-TGACGTCA-3’ or
half-CRE 5’-TGACG-3’ and 5’-CGTCA-3’ elements pre-
sent in the promoters of target genes. In somatic tissues,
CREB activates transcription following phosphorylation
of a serine residue (S133 in CREB, S117 in CREM) in
the activation domain by several kinases and in response
to a variety of stimuli [3]. Serine phosphorylation results
in recruitment of the p300 and CREB binding protein
(CBP) coactivators with histone acetyl-transferase activ-
ities [4]. Transcription regulation by CREB is also
modulated by TORC (transducers of regulated CREB
activity) 1 and 2 that interact with the bZIP DNA bind-
ing domain independently of serine 133 phosphorylation
and modulate CREB interaction with the TAF4 subunit
of TFIID, thus potentiating transcription activation [5].
TORCs play critical roles in several physiological pro-
cesses such as glucose metabolism and obesity [6-9].
Multiple isoforms of CREM have been described that
act either as repressors or activators [10]. Follicle stimu-
lating hormone (FSH), by an as yet undefined mechan-
ism, modulates the usage of alternative polyadenylation
sites in mouse male germ cells, such that several desta-
biliser signals in the 3’ untranslated region of the
CREMτ activator isoform mRNA are eliminated leading
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to increased stability and the accumulation of the
CREMτ protein to high levels in post-meiotic round
spermatids [11,12]. In these cells, CREM bypasses the
requirement for phosphorylation through interaction
with the LIM-only domain protein ACT (activator of
CREM in testis) encoded by the Fhl5 gene [13] specifi-
cally expressed in haploid cells. Knock out of CREM in
mice leads to male sterility due to apoptosis of the
round spermatids showing that it plays an essential role
in spermiogenesis [14-16]. While loss of CREM leads to
apoptosis of round spermatids and a complete arrest of
spermiogenesis, only a handfull of CREM target genes
have been described.
Here we have used chromatin immunoprecipitation
coupled to massive parallel sequencing (ChIP-seq) to
identify CREM target genes in round spermatids in tes-
tis and CREB target genes in spermatogonia derived
GC1-spg cells. We identify more than 9000 genomic
loci most of which are cell-specifically bound. Of these,
more than 6700 target loci are occupied by CREM in
testis, yet the expression of only a small subset of these
genes are affected upon CREM knock out. We also
identify intergenic CREB and CREM binding loci some
of which are associated with H3K4 trimethylation sug-
gesting the existence of novel CREB and CREM regu-
lated transcripts.
Results
CREM binding sites in round spermatids of mouse testis
As previously reported, in testis, the CREMτ isoform is
strongly and selectively expressed in round spermatids
[12,15], while CREB is expressed in spermatogonia, Sertoli,
Leydig and intertubular cells, but not in round spermatids
(Additional File 1, Fig. S1A and B). To identify CREMτ
binding sites, we performed duplicate ChIP-seq using anti-
CREMτ antibody, or anti-GFP antibody as control, and
formaldeyde-fixed testis chromatin from adult mice. We
reproducibly identified around 6792 CREM-bound geno-
mic loci (Fig. 1A and 1B, Additional file 2, Fig. S2, Addi-
tional file 3, Table S1). Of these loci, 80% were located in
the promoters of annotated RefSeq genes, but a significant
number were also located in intragenic regions corre-
sponding to potential alternate promoters, and in inter-
genic regions with no annotated RefSeq transcripts (see
below). Amongst the CREM targets are 46 miRNAs, some
of which have been described as having a brain-specific
function (Additional file 4, Table S2 and see below).
We used ChIP-qPCR to validate CREM binding to
sites that showed high, medium and low occupancy in
the ChIP-seq experiments. We compared CREM ChIP
to control ChIP with anti-GFP antibody at a series of
identified binding sites and with an intragenic region
from the bone morphogenic 2 inducible kinase (Bmp2k)
gene as a negative control and the testis-specific
angiotensin I converting enzyme (Ace) promoter [17] as
a positive control (Fig. 1C). These experiments con-
firmed binding of CREM to the tested promoters com-
pared to the Bmp2k control. Strong occupancy of the
intraflagellar transport 172 homolog (Ift172) and small
nuclear ribonucleoprotein polypeptide A (Snrpa) loci
was observed, but no significant occupancy of the surfeit
gene 6 (Surf6) locus was seen, when compared to the
background of the anti-CREM antibody as defined by
the signal seen using the Bmp2k control. All loci defined
by more than 40 clustered reads were significantly
enriched in qPCR, not all loci defined by under 40 reads
showed enrichment. This number was therefore used as
a cut off to obtain a high confidence list.
Bioinformatic analysis of the binding sites showed that
only 13% contained a full consensus CRE element, the
majority contained either a CRE with one mismatch or
one or several half-CRE elements (Fig. 1A). We also
identified a significant fraction of sites where no CRE
(17%) or half CRE (41%) could be observed. To deter-
mine whether an additional conserved sequence motif
could be identified in these sites, the 100 most highly
occupied regions were analysed using the Meme pro-
gramme [18]. This analysis showed that the only fre-
quently occuring motif corresponded to the SP1 binding
site. No CRE or CRE related motif could be detected in
this way and no novel alternative CREM binding motif
could be identified. Loci containing full CREs generally
showed a higher occupancy as 90% of these sites were
defined by more than 100 clustered reads, while only 5%
of the no CRE class fell into this category. Analysis of
the location of CREM binding sites with respect to the
transcription start site (TSS) showed a very strong pre-
ference around -150 bp irrespective of the presence of a
CRE-related element (Fig. 1B).
To make a global correlation between promoter occu-
pancy by CREM and transcription, we performed ChIP-
seq using an antibody against trimethylated lysine 4 of
histone H3 (H3K4me3). Trimethylation of this residue is
tightly associated with transcription activity, a high den-
sity of this mark overlapping the 5’end of the gene indi-
cates either its transcription or the presence of a poised
preinitiation complex [19]. Comparison with the CREM
ChIP-seq data set indicates that 95% of CREM bound
promoters (ie with CREM occupied loci between -1000
and +500 bp with respect to the TSS) show H3K4me3.
(Additional file 3, Table S1). However, in this experi-
ment we cannot exclude that some genes are inactive in
round spermatids where CREM is bound, but are tran-
scribed at other developmental stages or in other cell
types within the testis. To make a more accurate com-
parison we compared CREM promoter occupancy,
H3K4me3 and gene expression using a transcriptome
data set of adult mouse spermatid gene expression [20].
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We identified 4934 CREM-occupied promoters showing
H3K4 trimethylation. Comparison with array data
showed that, while the 41% of probe sets on the array
showed expression values ≥51, these accounted for 84%
of the CREM and H3K4me3 associated genes (Addi-
tional file 5, Fig. S3A). We identified only 89 CREM
occupied promoters (1.7% of the total CREM occupied
proximal promoters) that were false negatives annotated
Figure 1 Summary of CREM Chip-seq data in haploid cells. A. Left hand pie chart shows genomic annotation of CREM binding sites with
respect to known RefSeq genes. Promoter associated sites are arbitrarily confined to the regions between -5000 and +2000 bp with respect to
the transcription start sites (TSS). The right hand pie chart indicates the frequency of occurrence of consensus or mutated CRE and half CREs at
the CREM binding sites. B. Frequency of binding site localisation with respect to TSS. C. CREM ChIP-qPCR on the indicated loci. The GFP ChIP-
qPCR is shown as control. Results are from three independent ChIP experiments. In panel C the numbers above each column represent the
corresponding number of clustered reads in the ChIP seq experiments.
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as having no H3K4 trimethylation, but represented
amongst the moderate to strongly expressed genes.
These results indicate not only that the vast majority of
CREM occupied promoters with H3K4 trimethylation
are indeed expressed, but that they are over-represented
amongst the higher expressed gene set. It should also be
noted that we fail to detect any significant H3K4me3 of
Leydig cell-specific genes such as Cyp17a1 and Star and
little or no signal was seen for the Rhox genes that
are specific for Sertoli cells. Thus, in agreement with the
above data, the contribution of these cell types to
the profile is negligible, indicating that the majority of
the signal comes from transcription of genes in the
germ cell lineage.
Differing repertoires of CREM and CREB binding sites in
round spermatids and spermatogonia GC1-spg cells
As mentioned above CREB is not expressed in round
spermatids, but is expressed in spermatogonia and in
the somatic cells in testis. Due to its expression in sev-
eral of the cell types that make up the testis, we cannot
use total testis chromatin, even from early post-natal
animals, for the ChIP-seq as we would be unable to dis-
tinguish in which cells CREB was occupying a given
promoter. We therefore used GC1-spg cells that are
immortalised spermatogonia [21] and express CREB, but
not the CREMτ activator form (Additional file 1, Fig.
S1B). ChIP-seq experiments in these cells using anti-
CREB antibody allowed the identification of around
4398 binding sites (Fig. 2A, Additional file 2, Fig. S2 and
Additional file 6, Table S3).
These results were confirmed by ChIP-qPCR where we
observed significant, but variable occupation of all of the
tested promoters. In this case even loci with small num-
bers of clustered reads showed significant enrichment with
respect to the Bmp2k control (Fig. 2C). The majority of
these promoters were also occupied by pol II (Fig. 2D).
Similar to what was observed with CREM, most CREB
binding sites were observed in the promoters of anno-
tated genes, but a signficant number of intra- and inter-
genic sites were also observed. Bioinformatic analysis
showed that only a small number comprise full cannoni-
cal CREs and we identify a subset of sites with half-CRE
or no identifiable CRE (Fig. 2A). Also similar to CREM,
CREB binding sites are preferentially located around
-150 relative to the TSS (Fig. 2B).
To assess the association of CREB loci occupancy
with transcriptional activity, we further performed
H3K4me3 and pol II ChIP-seq in GC1-spg cells. Com-
parison with CREB occupancy shows that around 60%
of CREB-occupied loci are associated with high levels of
pol II and H3K4me3 in these cells (Fig. 3A, clusters B
and C), while a second group shows little or no pol II
and H3K4me3 (Fig. 3A, cluster A and see also
Additional file 6, Table S3). Comparison with publically
available array data for GC1-spg cell gene expression
(GSE19355) showed that similar to what was observed
in round spermatids, CREB and H3K4me3 occupied
promoters were strongly over-represented in the highly
expressed gene set (Additional file 5, Fig. S3B).
We next compared the repertoires of CREB and
CREM binding sites in round spermatids and in GC1-
spg cells. To identify cell-specifically occupied sites, we
took the coordinates of the CREB binding sites and
determined the read density in the CREM data set in a
window of +/- 5 kb around these coordinates. If CREM
and CREB occupy the same sites, there will be a high
density of reads at these coordinates in both data sets.
This comparison shows that a subset of loci show high
occupancy in both cell types (Fig. 3B, cluster B), but the
majority are cell-specifically occupied in either GC1-spg
cells (Fig. 3B, cluster A) or in round spermatids (data
not shown). In particular, CREM occupies a large set of
sites in the round spermatids that are not occupied by
CREB in GC1-spg cells.
For example, the genes encoding protamines 1, 2, and
3 and transition protein 2 are all selectively expressed
in round spermatids and clustered on chromosome 16.
Multiple binding sites are occupied by CREM at this
locus in round spermatids, but not by CREB in GC1-
spg cells and the locus shows H3K4 trimethylation only
in testis (Fig. 4A). Similarly, the ornithine decarboxylase
antizyme 3 (Oaz3) is occupied by CREM and active in
testis, but not by CREB in GC1-spg cells, while the
opposite is observed for the natriuretic peptide precur-
sor type B (Nppb) locus (Fig. 4B and 4C). We also
investigated occupancy of the well characterised CRE in
the somatostatin (Sst) promoter [22]. Sst is not
expressed in testis or in GC1-spg cells as shown by the
absence of H3K4me3 and pol II (data not shown), and
the promoter CRE is not occupied in either cell type.
However, CREB selectively occupies an alternative and
conserved intragenic site in GC1-spg cells (Fig. 4D).
These results show that CREM and CREB occupy dis-
tinct but overlapping repertoires of binding loci in
round spermatids and GC1 cells and that genes specifi-
cally activated in round spermatids are in general not
occupied in GC1 cells, but become accessible during
germ cell development in vivo.
In total, 9037 distinct CREB and CREM binding loci
can be identified combining the ChIP-seq in round sper-
matids and GC1-spg cells. Despite the wide occupancy
of potential binding sites by CREM in haploid cells, not
all possible sites (i.e. full CREs) are occupied as the CRE
element in the Mitf-m promoter that is specifically
active in the melanocyte lineage, or the Hoxa5 gene are
not occupied in GC1-spg or haploid cells (data not
shown). These results show the existence of different
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Figure 2 Summary of CREB Chip-seq data in GC1-spg cells. A-D. The layout is as described in Fig. 1.
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Figure 3 Correlative analysis of CREB and CREM binding site occupancy. A. Association of CREB, pol II and H3K4me3 in GC1-spg cells.
Comparison of pol II and H3K4me3 tag density in the region of +/- 5 kb around the CREB-occupied loci. Clustering analysis identifies 3 classes,
A; CREB loci with low or no pol II and H3K4me3, B-C; CREB loci with high pol II and H3K4me3 corresponding to transcription on the sense and
anti-sense strands, respectively. B. Comparison of CREM tag density in the region of +/- 5 kb around the CREB-occupied loci. Clustering identifies
2 groups A; CREB loci with low or no CREM and B; CREB loci with high CREM. C. Venn diagramme comparing common and cell-specific CREB/
CREM occupancy of binding sites using the CREB data in panel B and the equivalent analysis of the CREM occupied loci (data not shown).
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classes of binding sites, those that are rather generally
accessible, and a larger set that are occupied in a cell
type-specific manner.
Genes directly regulated by CREM in haploid cells
CREM inactivation leads to round spermatid apoptosis
at an early stage. To understand the basis of this effect,
Beissbarth et al [23] used subtractive hybridisation and
Affymetrix arrays to identify genes that are deregulated
upon CREM inactivation. We used the results of the
Affymetrix analysis to identify those genes whose pro-
moters are bound by CREM and are direct targets. A
set of 127 genes were reported to be deregulated, 102 of
which are down-regulated, in CREM mutant testis [23]
Figure 4 Specific occupancy of target promoters by CREM and CREB. A-D. Graphic representation of ChIP-seq results as. wig format files in
UCSC web browser at the indicated loci. The same format has been used for Figs. 6 and 7 as well as Additional file 1, Figs. S4 and 5. The ChIP-
seq results for CREB and CREM in GC1-spg and testis haploid cells respectively are shown along with results for H3K4me3 in GC1-spg cells (K4-
GC1) and testis (K4-T). In addition, the mammalian conservation track from the UCSC browser is also included. CREM and CREB binding peaks are
indicated by arrows.
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(http://www.dkfz.de/tbi_old/crem/cremgenes.txt). Of
these, only 58 are direct CREM targets with one or sev-
eral CREM binding sites in their promoters. (Fig. 5A
and Additional file 7, Table S4). Surprisingly however,
two of these Rundc3a and Cnn1 do not show significant
H3K4me3 and are thus likely not expressed in the testis
of the animals used in our experiments.
Analysis of the CREM binding sites in the promoters
of regulated target genes shows that not all have con-
sensus CRE elements, the profile is in fact similar to
that seen in the global population of target genes, and
some of the directly regulated genes do not contain any
identifiable CRE or half CRE elements (Fig. 5B). It has
previously been suggested that the presence of a TATA
element is required for a gene to respond to cAMP sti-
mulation via CREB [24], however, of the 58 CREM regu-
lated promoters, only 6 have a consensus TATA
element. This frequency is close to that seen in the gen-
ome as a whole [25]. Thus the presence of a TATA ele-
ment is not a pre-requisite for regulation by CREM and
is not enriched in CREM regulated promoters. Indeed
many other CREM bound promoters have TATA ele-
ments and yet are not de-regulated in the absence of
CREM.
The above results show that only 1% of the total occu-
pied promoters are actually regulated by CREM in hap-
loid cells. The expression of the vast majority of
occupied genes is not affected by loss of CREM.
CREB/CREM target promoters involved in other
physiological processes
In addition to germ cell development, CREM and CREB
are involved in many other physiological processes. We
examined whether they occupy the promoters of target
genes involved in other cell-specific functions. For exam-
ple, the Clock and Period (Per) 2 genes are expressed in
both testis and GC1-spg cells, yet their promoters are spe-
cifically occupied only in round spermatids by CREM
(Additional file 8, Fig. S4A and B). Thus, while the expres-
sion of these genes is not haploid cell-specific, the CREB/
CREM binding sites of their promoters are selectively
occupied in germ cells. Moreover although not regulated
by CREM in testis (see below), Per2 expression is for
example regulated by CREB in response to parathyroid
hormone activation of the cAMP signalling pathway in
chondrocytes [26]. Thus at least in this case, the CREM
promoter occupancy is indicative of potential regulation in
other cell types by physiological signalling pathways.
Mmu-mir-132 and mmu-mir-219-1 are two CREB
regulated brain-enriched miRNAs that regulate circadian
rythmn and in the case of mir-132, neuronal morpho-
genesis [27,28]. At the mmu-mir-219-1 locus, a CRE ele-
ment located downstream of the miRNA and upstream
of the Ring1 gene is occupied in both haploid and GC1-
spg cells by CREM and CREB respectively (Fig. 6A, and
Additional file 4, Table S2). Furthermore, an extended
region of H3K4 trimethylation in testis and in GC1-spg
cells is observed indicating expression of both the
miRNA and the adjacent Ring1. A similar observation
was made at the mmu-mir-132 locus (data not shown).
Mmu-mir-9-3 is a miRNA involved in silencing the neu-
ronal transcription factor REST [29]. In contrast to the
mmu-mir-219-1 and mmu-mir-132 loci, the mmu-mir-
9-3 locus is specifically bound by CREM and active in
testis and not GC1-spg cells (Fig. 6B). Thus in testis and
in GC1-spg cells, CREM and CREB occupy the promo-
ters of genes that are involved in specific processes in
other cell types, and that although expressed in testis
play no known role in spermatogenesis.
As CREB/CREM are involved in many physiological
and metabolic processes, we used the KEGG pathway
function of DAVID annotation (http://david.abcc.ncifcrf.
gov/) to make a more comprehensive identification of
potential CREB/CREM target genes in physiological
functions (see Additional file 9, Table S5). This analysis
identified many potential target genes not only in cell
cycle and proliferation, but also in metabolic functions
such as insulin signalling.
We also noted that CREB and CREM occupy their own
promoters and those of several of their essential cofactors.
The complex CREM locus comprises several alternative
promoters where CREM/CREB occupy a site upstream of
the major transcript that is expressed in both testis and
Figure 5 CREM bound genes that are deregulated upon CREM
inactivation in testis. A. Venn diagramme comparing the total
number of genes with CREM binding in their promoters with the
genes deregulated in the Affymetrix analysis of Beisbarth et al. B Pie
chart indicating the frequency of occurrence of consensus or
mutated CRE and half CREs at the CREM binding sites in the
promoters of the 58 deregulated genes.
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Figure 6 Binding of CREB and CREM to the promoters of brain enriched miRNAs in haploid and GC1-spg cells or to the promoters of
the coactivator CBP (Crebbp) and TORC1 (Crtc1) genes. A-D. Graphic representation of ChIP-seq results in UCSC web browser at the
indicated loci using the nomenclature described in Fig. 4.
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GC1-spg cells, although as indicated above, the CREMτ
activator isoform is not present in these cells (Additional
file 8, Fig. S4C). Weak H3K4me3 of two of the alternate
promoters is also seen specifically in testis. The genes
encoding the coactivators CBP (Crebbp), p300 (Ep300)
and TORC1 (Crtc1) are expressed in GC1-spg cells and
testis, but their promoters are occupied only in haploid
cells by CREM (Fig. 6C and 6D). These results suggest
that in the appropriate cell type or in response to the
appropriate signal CREB or CREM may regulate expres-
sion of their coactivators (see also [30,31]).
Novel transcripts and loci potentially regulated by CREM
and CREB
It is striking that the majority of CREB and CREM binding
sites are located at around -150 bp with respect to the
TSS. The tight distance correlation between the CREB/
CREM binding site and the transcription start site
prompted us to investigate whether the CREB and CREM
binding sites that are located in intergenic regions with no
currently annotated RefSeq genes correspond to cryptic
and as yet unidentified promoters of novel transcripts.
Many of the intergenic sites are not associated with
known RefSeq genes, but are associated with annotated
EMBL transcripts or predicted genes most of which are
not well characterised (See Additional files 3, Table S1 and
Additional File 6, Table S3). However, there are also a set
of loci with no nearby RefSeq annotation (Additional file
10, Table S6). Many of these loci are not associated with
any predicted transcripts, but others lie close to UCSC
gene predictions or Genbank transcripts corresponding to
non-coding or uncharacterised RNAs. For CREM, 80% of
these sites contain a CRE or half CRE, while for CREB,
55% contain CRE-related elements (Fig. 7A).
A subset of these regions potentially comprise active
promoters as they are marked by H3K4me3. For exam-
ple, on chromosome 15, downstream of the Slc38a2
gene, is a CREB occupied locus that correlates with a
peak of H3K4me3 and pol II (Fig. 7B). The pol II is dis-
tributed as a peak close to the H3K4me3 peak marking
the 5’end of the transcript and a lower density corre-
sponding to the potential transcribed region. A similar
pol II distribution is seen over the Slc38a2 gene where
an additional peak is seen at the transcription termina-
tion site downstream of the gene, a profile typical of
that previously observed for pol II [32,33]. This second
region therefore appears to comprise an additional as
yet uncharacterised transcript that can be potentially
regulated by CREB. A similar example is seen on
chromsome 5 at the Rnf4 locus where peaks of CREB
and H3K4me3 and pol II are seen downstream of the
Rnf4 gene that are characteristic of a promoter driving
the expression of an anti-sense transcript with paused
and elongating pol II. (Fig. 7C).
In other cases, the CREB occupied sites lie upstream
of known promoters and are associated with H3K4me3,
paused pol II, but little or no elongating pol II (Addi-
tional file 11, Fig S5A and B). These may correspond to
alternative promoters that are not engaged in productive
transcription, or distal enhancer elements. In contrast,
other conserved loci show occupation by CREB and/or
CREM, but low or no H34Kme3 and pol II. Again these
may correspond to remote enhancer elements. Correla-
tion between the CREM/CREB, H3K4me3 and pol II
data sets thus allows the identification of potential
CREB regulated novel transcripts, promoters, or distal
enhancer elements.
In the course of this analysis we also noted multiple
CREB binding sites and an exceptionally high RNA pol
II density and over the region covering the MENε/b and
Malat1 (metastasis associated in lung adenocarcinoma
transcript 1) loci (Additional file 11, Fig. S5C). These
correspond to two non-coding RNAs. The precise func-
tion of Malat1 is not known [34], while the MEN tran-
scripts are involved in the formation of nuclear
paraspeckles [35]. These two neighbouring loci have the
highest pol II density observed in the data set and are
thus very highly transcribed in GC1-spg cells.
Discussion
An extended repertoire of CREM/CREB binding sites
We have used ChIP-seq to identify CREM binding sites
in round spermatids and CREB binding sites in GC1-spg
cells. This is the first study of CREM target promoters
directly in a physiologically relevant tissue in vivo and
represents the most comprehensive experimental analy-
sis of murine CREB/CREM regulatory potential to date.
Our data identify 9037 binding loci that are occupied in
either a common or cell-specific manner. The majority
of binding sites cluster to a preferential location in the
nucleosome free region around 150 nucleotides
upstream of the TSS. This observation differs from a
bioinformatic analysis showing that the CRE element is
preferentially located around -45 bp relative to the TSS
[36]. This discrepancy may be explained by the fact that
many of the observed binding sites are half CREs,
mutated or non-CRE elements, that many not have been
identified bioinformatically. Thus, while full CREs may
be closer to the TSS, the overall occupancy profile is
centered around -150 bp. Moreover, a bioinformatics
analysis of testis-specific promoters indicated a preferen-
tial presence of CRE-like elements rather than full con-
sensus CREs [37]. This bias is also reflected in the
experimental data.
Previous studies based on ChIP-chip analysis identified
smaller repertoires of sites [30,38], while ChIP coupled
to sequencing of concatenated tags in a SAGE type ana-
lysis identified more than 6300 CREB binding sites [31].
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Figure 7 Identification of novel CREB occupied regulatory elements and transcripts. A. Pie chart indicating the frequency of occurrence of
consensus or mutated CRE and half CREs at the CREM and CREB intergenic binding sites. B-C. Graphic representation of ChIP-seq results in
UCSC web browser at the indicated loci using the nomenclature described in Fig. 4, with the addition of the GC1-spg pol II ChIP-seq data set. In
panels B-C, the presence and direction of transcription of potential novel transcripts in the regions covered by elongating pol II are indicated by
arrows.
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Based on this data, it has been suggested that there may
be between 5000 and 19,000 binding sites in the human
genome. Indeed, more than 10,000 full CREs have been
predicted in the human genome of which around 4000
are suggested to be critical for function based on their
conservation in mouse or the fact that they are present
as a repeated cluster in promoter regions [30]. Our
results show that in round spermatids around 622 full
CREs are occupied while in GC1-spg cells around 613
CREs are occupied. Thus, many CREs are occupied
neither in haploid cells nor in GC1-spg cells showing
that the full repertoire of CREB/CREM binding sites
exceeds the 9000 that we have identified.
From comparison of ChIP-chip in three different cell
lines it has previously been suggested that CREB occupies
almost the same set of target genes in each cell type, and
that specificity of gene regulation is conferred not by
selectivity in occupation of target sites, but by coopera-
tion of CREB with other cellular factors [30]. In contrast,
by ChIP and in vivo footprinting in hepatoma and PC12
cells or cortical neurons, Cha-Molstad et al., [39] showed
that many sites were occupied in a cell specific manner.
Our data clearly favour a model in which occupation
of potential CREB/CREM binding sites is largely cell-
specific although this does not exclude other criteria that
specify which of the occupied sites are actually regulated
by CREB and CREM. We have compared our murine
data sets with those of Zhang et al obtained by ChIP-chip
in human HEK cells [30]. We identified murine ortholo-
gues for 2003 of the CREB-occupied human promoters.
Of these, 493 are occupied by CREB in GC1-spg cells,
and 922 occupied by CREM in haploid cells. This com-
parison further highlights the cell-specificity of CREB/
CREM promoter occupancy.
Cha-Molstad et al., also suggested that CREB preferen-
tially occupies loci that are expressed and marked with
H3K4 methylation. As an example, they show that occu-
pancy of the well studied somatostatin (Sst) CRE corre-
lates with its expression. In our experiments, the Sst
locus is expressed neither in testis nor in GC1-spg cells
and the promoter CRE is not occupied by CREB or
CREM. In contrast, CREB occupies a novel and con-
served intronic site in GC1-spg cells that does not con-
tain any CRE-related element. However, a more global
analysis of our CREB data set shows that a majority of
CREB occupied promoters are also characterised by high
pol II occupancy and H3K4 trimethylation. Thus the idea
that CREB preferentially occupies promoters of expressed
genes is generally valid. Similarly, CREM-occupied genes
in haploid cells are over-represented amongst the highly
expressed gene set On the other hand, there are both
promoter and intergenic sites that are not closely asso-
ciated with H3K4 trimethylation. Thus, expression is
neither an absolute pre-requisite nor outcome of CREB/
CREM occupancy. Moreover as discussed above, there
are promoters that are active in both testis and GC1-spg
cells, but bound only by CREM in testis. There must
therefore be additional factors that influence occupancy,
such as DNA methylation or competition with other fac-
tors whose binding sites overlap that of CREB [30,39].
Insights into the specific role of CREM in spermiogenesis
During spermatogenesis, the gene regulatory programme
in haploid cells is characterised by the activation of a
large set of genes that are uniquely expressed in this cell
type and by the existence of specialised mechanisms and
factors that control their expression [40-42]. Given this
specialisation, one could have imagined that in contrast
to somatic cells, CREM would occupy a restricted set of
loci corresponding to genes that are specifically
expressed and regulated in these cells. Indeed at some
loci, such as the protamine and transition protein genes,
there is a developmental logic to CREM promoter occu-
pancy. In contrast however, there are numerous exam-
ples of genes which are expressed in testis and GC1-spg
cells, but are occupied only by CREM in haploid cells.
Similarly, CREM also binds the promoters of genes that
have no known or obvious function in spermatogenesis.
Thus, contrary to what one may have expected for a
highly specialised cell type with a unique gene expres-
sion programme, haploid cells clearly provide a much
more permissive environment for accessibility than
GC1-spg cells.
It has previously been shown that TBP, TFIIB, RNA
polymerase II, and TFIIA are all strongly up-regulated
in haploid spermatids [43,44]. It has been proposed that
overexpression of the general transcription machinery at
this stage is required to produce the large amounts of
some mRNAs that have to be synthesised and stored for
translation during the elongation and remodeling phase
[43]. There is also evidence that overall mRNA levels
are generally higher in haploid cells than in somatic
cells due to ‘promiscuous’ transcription where in addi-
tion to transcription of highly expressed testis-specific
genes and of normal ‘housekeeping’ genes, many other
genes are also transcribed albeit at lower levels [43]. In
agreement with this idea, our present ChIP-seq experi-
ments show widespread occupancy by CREM of target
genes that have no specific role in spermatogenesis, but
whose promoters are active in haploid cells. The
euchromatin of round spermatids is therefore highly
accessible for transcription factor binding which,
together with high levels of the basal transcription
machinery, may lead to the expression of a large set of
genes and generally higher mRNA levels.
Strikingly, only a very restricted set of CREM-occupied
genes are affected by CREM inactivation. Comparison of
the 127 genes whose expression is affected with those
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that are bound by CREM identifies 58 genes as direct
targets. For this analysis, we used only the Affymetrix
data of Beissbarth et al [23] that may underestimate the
real number of affected genes. At the time of this study,
many haploid expressed genes were not well charac-
terised and were identfied only as ESTs. For example, we
have previously characterised H1T2 (H1fnt) a histone H1
variant specifically expressed in haploid cells [45]. The
H1fnt promoter is occupied by CREM, selectively acti-
vated in round spermatids and is therefore a direct
CREM target. The full data set of Beissbarth et al actually
comprises more than 367 regulated transcripts many of
which are only identifed as ESTs. If the proportion of
direct CREM targets from the Affymetrix data can be
extended to the full set, this would suggest that CREM
directly regulates between 150-200 genes in male germ
cells. This number still represents only a small fraction of
the CREM bound promoters. CREM clearly occupies
many more promoters than it actually regulates. Neither
the presence of a full CRE nor a TATA element are
pre-requisites to predict whether a gene will be regulated
by CREM. The criteria that determine whether a promo-
ter will be regulated or not by CREM remain to be
determined.
Inactivation of CREM leads to an early apoptosis of
haploid cells around step 4 of their development [14,15].
Amongst the direct CREM targets are genes that encode
protamines, transition proteins and outer dense fiber
protein whose expression initiates around this stage, but
whose gene products are required only later during the
elongation stage. Reduced expression of these genes
may account for the reduced sperm count and abnorm-
alities seen in heterozygous CREM mutant mice, but do
not explain the early round spermatid apoptosis. Pre-
viously, Beissbarth et al [23] suggested that down regu-
lation of the anti-apoptotic genes Bcl2 and Bcl6b
(BAZF) may contribute to germ cell apoptosis. Bcl2 is
not a direct CREM occupied promoter (although the
promoters of the related Bcl2l1, Bcl2l11 and Bcl2l13
genes are occupied by CREM), but Bcl6b is a direct tar-
get. Apoptosis may potentially result from direct deregu-
lation of this gene or of one or several of the other
direct CREM target genes involved in signal transduc-
tion and metabolic processes.
Conclusions
Together our results have identified a large repertoire of
CREM bound loci in haploid cells of which a small subset
involved in signalling and metabolic processes are
deregulated upon CREM inactivation and may explain
the haploid cell apoptosis. In contrast to previous studies
on smaller data sets, we have shown that promoter occu-
pancy by CREB and CREM is highly cell specific in
haploid and GC1 cells. This is the most comprehensive
evaluation of CREB/CREM regulatory potential to date
and we have identified a large set of promoters that may
be regulated by these factors in different tissues and phy-
siological processess. Correlation between the CREM/
CREB, H3K4me3 and pol II data sets has identified many
novel potential CREB regulated transcripts, and revealed
the presence of CREB at novel start sites and distal regu-
latory elements.
Methods
ChIP-seq
Chromatin was prepared from the testes of 12 week old
adult 129/SV mice. Animal breeding and manipulation
were performed according to French national ethical
standards using approved protocols. The animals were
sacrificed and the testes removed and opened directly in
20 ml fixing solution (0.4% formaldehyde in 1× PBS) in
a Petri dish. Seminiferous tubules were fixed for 10 min-
utes with agitation. The cross-linking reaction was
stopped by adding 2 ml 2 M glycine solution. Seminifer-
ous tubules were then centrifuged at 4000 rpm and the
pellet was lysed with 2 ml cell lysis buffer (50 mM Tris
pH8.0, 10 mM EDTA, 1% SDS) for 15 minutes. GC1-
spg cells were obtained from the ATCC collection and
cultured in DMEM with 10% foetal calf serum. Cells
were grown to 90% confluency and crosslinked with for-
maldehyde 0.4% for 10 min at room temperature and
the reaction was stopped by adding glycine to final con-
centration 0.2 M for 10 minutes at room temperature.
Fixed cells were rinsed twice with PBS and resuspended
in lysis buffer. Lysate from cells or testis was sonicated
30 min (10 sec on/30 sec off) in Diagenode water bath-
sonicator and centrifuged at 14000 rpm for 10 min. The
cleared supernatant was used immediately in ChIP
experiments or stored at -80°C. ChIP was performed by
standard procedures.
ChIP-seq was performed using an Illumina GAII
sequencer and the raw data analysed by the Illumina
Eland pipeline. Peak detection was performed using the
MACS software (http://liulab.dfci.harvard.edu/MACS/)
[46], and the peaks annotated using GPAT ([47], http://
bips.u-strasbg.fr/GPAT/Gpat_home.html). Peak detection
with MACS was performed using the GFP-ChIP as nega-
tive control. Clustering was performed by first generating
density (.wig format files) counting the number of tags in
a 25 pb sliding window for each ChIP-seq data set. The
coordinates of the CREB binding sites were used as refer-
ence, and the tag density for the Pol II and H3K4me3 data
sets were extracted from the. wig files in the 10 kb around
the CREB site. A matrix of binding sites and densities was
generated and subjected to K-means clustering using the
Cluster 3.0 software (http://bonsai.ims.u-tokyo.ac.jp/
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~mdehoon/software/cluster/software.htm#ctv). The clus-
tered matrix was visualized using Java TreeView. (http://
jtreeview.sourceforge.net/).
Comparison of the ChIP-seq data with the array expres-
sion data was carried out by first performing an RMA nor-
malisation of the mouse spermatid expression. Cel files
from [20] and from the mock silenced GC1-spg data sets
in the GEO data base (GSE19355). Excel files with the
normalised data were compared to those comprising a list
of CREM (or CREB) and H3K4me3-occupied promoters,
thus assigning an expression value to each of the corre-
sponding genes.
The following antibodies were used: the anti-CREMtau
rabbit polyclonal antibody has been previously described
[14,48], CREB (06-863, Upstate), H3K4me3 (MC315 04-
745, Millipore), Pol II (H-224 Sc-9001 Santa Cruz).
Real-time PCR was performed on a Roche Lightcycler
using Roche SYBR Green mix. The following primer
sequences were used. Ift172: 5’-TTTTGCCTCTCGTAG-
CACCT-3’, 5’-ATGCAAACCTAACGCAAACC-3’
Gosr2: 5’-TAAAACTGGGAGGGATGCAG-3’, 5’-
CTAGGCCCATCTCATTTCCA-3’
SnrpA: 5’-CACAACGCTCTTGAAGGTCA-3’, 5’-
GGAACGGACCAATCAAAGAA-3’
Cdc6: 5’-AGACCTGGGGCTGTCCTATT-3’, 5’-
CCAAAGCCGCTCTACTTCAG-3’ Camk2d: 5’-AAG-
CACGAGCACATAAGCAA-3’, 5’-GCAGATTTA-
GAGGCCTACGG-3’
Cd63: 5’-ACCTGGTTTTGCCATCTCTG-3’, 5’-
AAGCCTTAGAGCTCCCTTGC-3’
Ace: 5’-GCTGGCACATTGCTCTATGA-3’, 5’-AGCA-
GAGCAGCAGAAAGAGG-3’
Ankrd52: 5’-TGACGTCAGGGAGAGAGCTT-3’, 5’-
CCCCATCACAAGGAGAGAAA-3’
SURF6: 5’-GCCTTTCCCTTCATTTCCTC-3’, 5’-
GACCTGAGTATGGCGTGGAT-3’
Bmp2k intragenic: 5’-TCCCTGCACGTACTT-
TAGGC-3’, 5’-TTGGAGCACTCAAAGGTGTG-3’
Rtbdn: 5’-TCCACGGTGCTGAAATATGA-3’, 5’-
CCAGGAACCGAGTTACAGGA-3’
Stat3: 5’-CTCCCCCACGCAATCTAGTA-3’, 5’-AAG-
CATTTGGGTTTGTGGAG-3’
Pcna: 5’-GGGTTGGTAGTTGTCGCTGT-3’, 5’-
AGCACCTTCTTCAGGATGGA-3’
Cfos: 5’-TTAGGACATCTGCGTCAGCA-3’, 5’-
CCCGTCTTGGCATACATCTT-3’
Fn1: 5’-CCTCCCTTTCCTTCGAGTCT-3’, 5’-
GCCAGGTCTGGGACTAGAGA-3’
B2m: 5’-CTGACCGGCCTGTATGCTAT-3’, 5’-
TCCACCCTGTAGCCTCAAAG-3’
Crebzf: 5’-CCGGGTAGTACCGATGAGTG-3’, 5’-
CTTCGCTCCAGCCAGAGTAT-3’
Klf7: 5’-CCAGCGTGTACAGTGCAGAT-3’, 5’-
TGTCAGTGAGTTTGCGTTCC-3’
Bioinformatics analysis
Detection of CRE and half CRE elements in the CREB
and CREM bound loci was performed by first extracting
a region of 500 nucleotides centered on the peak sum-
mit. These sequences were then analysed using the
motif search programme of Genomatix software. Addi-
tional analysis of the bound regions was performed
using the Meme programme (http://meme.nbcr.net/
meme4_4_0/cgi-bin/meme.cgi) [18].
Additional material
Additional file 1: Figure S1: Expression of the CREB and CREMτ
proteins in adult mouse testis.A. Immunofluoresence on sections from
adult mouse testis with the anti-CREB and CREMτ antibodies. The signal
for the antibodies in red, the Hoechst stained nuclei and the merged
views are show as indicated. Representative examples of the different
cell types are indicated by arrows. L; Leydig cells, S; Sertoli cells; Sp;
spermatogonia; P; pachytene spermatocytes, I; intertubular cells, R; round
spermatids, E; elongated spermatids. These results reveal a distinct
expression of CREB and CREMτ in the testis, where CREB is present in the
spermatogonia, the Sertoli, Leydig and intertubular cells, while CREMτ is
present in haploid round spermatids. 20 fold magnification. B. Western
blots with the CREMτ and CREB antibodies on 20 ug of extracts from the
indicated cells or tissues. ES is undifferentiated mouse E14 embryonic
stem cells, COS is COS-1, and 3T3 is NIH3T3. The CREB antibody detects a
single polypeptide corresponding to CREB in each of the extracts, while
the CREMτ antibody detects the CREMτ proteins only in the testis
extract.
Additional file 2: Figure S2: Example of ChIP-seq data over an
11,191,448 bp region of mouse chromosome 3qA3-3qB. The results
for CREB and CREM in GC1 and haploid cells respectively are shown
along with the ChIP-seq for H3K4me3 in GC1 cells (K4-GC1) and testis
(K4-T). Representative CREB, CREM binding sites are indicated. Active
promoters marked by H3K4me3 are also indicated. The * in the CREB
and CREM chanels show examples of loci that are specifically occupied
GC1 cells or haploid cells respectively. The * in the K4-GC1 and K4-T
show examples promoters that are specifically or preferentially active in
GC1 cells or testis, respectively.
Additional file 3: Table S1: CREM bound loci in mouse male haploid
germ cells. Excel table of annotated loci bound by CREM. Page 1 shows
annotation of bound loci to RefSeq genes. N is number, Chr
chromosome, start and end shows the coordinates of the binding sites
and summit, the coordinates of the center of the site. The number of
clustered reads and the pvalue and the local fold enrichment are
indicated. For annotation, the RefSeq transcript ID, the gene symbol, and
TSS coordinates are indicated along with the distance between the
summit of the peak and the TSS. No match signifies that there was no
RefSeq annotation within 5 kb from the peak summit position. The
presence of a perfect CRE, a CRE with 0 or 1 mismatch or a half CRE are
then indicated. The H3K4me3 status of the loci is also indicated. Page 2
shows annotation of bound loci to Ensembl transcripts. Layout is as in
page 1 except that the RefSeq transcripts are replaced by Ensembl
annotation.
Additional file 4: Table S2: MiRNAs that are targets of CREM in
mouse male haploid germ cells. Excel table of CREM bound miRNAs in
haploid cells. Layout is essentially as in Table 1.
Additional file 5: Figure S3: Comparison of CREM and H3K4me3
ChIP-seq with adult mouse round spermatid gene expression.A. The
probe set expression values were divided into classes of ≤ 10, 11-50, 51-
500 and ≥501 and the % of the total probe sets in each category are
represented by the black bars as a % of the total. The % of the total
number of CREM and H3K4me3 occupied promoters in each expression
category is shown with the shaded bars. B. A similar representation is
shown for the probe set expression values and CREB and H3K4me3
occupied promoters in GC1-spg cells.
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Additional file 6: Table S3: CREB bound loci in GC1 cells. Excel table
of binding sites. Page 1 shows annotation of bound loci to RefSeq
genes. Page 2 shows annotation of bound loci to Ensembl transcripts.
Layout is as in Table S1.
Additional file 7: Table S4: Comparison of genes whose expression
is affected by CREM inactivation in testis and CREM binding. Page 1
of the Excel table reproduces the Affymetrix data of Beissbarth et al., (1)
(http://www.dkfz.de/tbi_old/crem/cremgenes.txt) concerning genes
whose expression is deregulated in the testis of CREM knock-out mice.
Page 2 shows the data for CREM occupancy of the subset of loci that
map to the promoters of the genes in page 1. Note that some
promoters contain several CREM occupied sites; Page 3 shows the list of
the genes whose expression is deregulated from page 1 and whose
promoters are occupied by CREM.
Additional file 8: Figure S4: UCSC web browser graphic view of
CREB and CREM binding to the indicated loci.A-B. Selective binding
of CREM to the Clock and Per 2 promoters. C. CREB, CREM occupancy
and H3K4me3 over the Crem locus.
Additional file 9: Table S5: Functional annotation genes whose
promoters are occupied by CREM (page 1) and CREB (page 2).
Functional annotation was performed using the KEGG pathway of David
(http://david.abcc.ncifcrf.gov/). In addition to the list of genes in each
identified functional category, are shown the number of genes (gene
count) the % of the total number of genes, and pvalue.
Additional file 10: Table S6: Excel table of CREM and CREB bound
sites with no annotation to RefSeq genes or Ensembl transcripts.
Pages 1 and 2 show the data concerning CREM and CREB binding sites
for which no RefSeq annotation was found within 5 Kb of the peak
summit and which were designated ‘no match’ in Tables S1 and S3.
Layout is as in Table S1.
Additional file 11: Figure S5: A-B. UCSC web browser graphic view
of CREB, H3K4me3 and pol II occupancy of intergenic sites
upstream of annotated genes. In panel A, no elongating pol II is seen
between the upstream site and the annotated promoter, while in panel
B, a low level of elongating pol II is observed, suggesting the existence
of an alternative promoter. C. Multiple CREB binding sites and high pol II
occupancy of the locus encoding the Malat1 and MENε/b non-coding
RNAs.
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